Lv4
670 积分 2024-12-18 加入
Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer
18天前
已完结
Ivonescimab plus chemotherapy in patients with EGFR variant non-small cell lung cancer
18天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
中国变应性鼻炎诊断和治疗指南（2022年，修订版）
2个月前
已完结
Hormone therapy in ovarian granulosa cell tumors: a systematic review
2个月前
已关闭
First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis
2个月前
已完结
Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2–Low Metastatic Breast Cancer
2个月前
已关闭
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial
3个月前
已完结
Maintenance strategy in metastatic colorectal cancer: A systematic review
4个月前
已完结
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis
4个月前
已完结
皖公网安备34019202002308
